Afuco™ Anti-IL12+IL23 ADCC Therapeutic Antibody (Ustekinumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to IL12+IL23. Ustekinumab (INN, experimental name CNTO 1275, proprietary commercial name Stelara, Centocor) is a human monoclonal antibody. It is directed against interleukin 12 and interleukin 23, naturally occurring proteins that regulate the immune system and immune-mediated inflammatory disorders.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-063 |
| Pricing | Inquiry |
| Host | Human |
| Target | IL12+IL23 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | FuncS, IF, Neut, ELISA, FC |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |